Parliament Workbench
Data: Motions & questions to 19 Nov 2026

Written Question · S1W-20723 · Session 1

What procedures are in place to measure compliance by NHS Trusts in the labelling of medicinal products and associated package leaflets as …

Answered Asked by Margaret Jamieson Lab Lodged 6 Dec 2001

The question

To ask the Scottish Executive what procedures are in place to measure compliance by NHS Trusts in the labelling of medicinal products and associated package leaflets as required by Council Directive 92/27/EEC.

The answer

Answered by Malcolm Chisholm on 3 Jan 2002 · 28 days after it was lodged, 14 days after it was due

Requirements for the provision of drug information leaflets to patients are reserved matters which come under the remit of the Medicines Control Agency. Directive 92/27/EEC was incorporated into UK law by the Medicines (Marketing Authorisations etc) Regulations 1994 and the Scottish Executive supports its aim of ensuring that patients receive full and useful information. There is no formal procedure in place to measure compliance with these requirements in the NHS. Pharmacists are expected to comply with the requirements and standards laid down by their professional body, the Royal Pharmaceutical Society of Great Britain.

In the Official Report

No contribution in the Official Report cites S1W-20723 by reference.